Liu Yang, Xu Cheng, Wang Chengyu, Gu Fei, Chen Rui, Lu Jie
Department of Anaesthesiology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
Department of Anaesthesiology, Hainan Hospital of GLA General Hospital, Shanghai, China.
Front Med (Lausanne). 2022 May 6;9:857427. doi: 10.3389/fmed.2022.857427. eCollection 2022.
The innervation of the proximal humerus fracture is complicated and unclear. The use of interscalene nerve block has been effective as postoperative analgesia for patients, but the optimal concentration of usage is unknown.
This study was conducted on 30 patients with ASA I or II, who were planning to undergo a proximal humerus fracture operation. A dosage of 10 ml Ropivacaine was administered for the interscalene brachial plexus block (ISBPB) as determined using the up-and-down sequential method. The initial concentration of Ropivacaine in the first patient to receive ISBPB was 0.3%. After a successful or unsuccessful postoperative analgesia, the concentration of local anesthetic was decreased or increased, respectively, by 0.05% in the next patient. We defined successful postoperative analgesia as a visual analog scale (VAS) score of < 4 at rest, within the initial 8 h after ISBPB. The analytic techniques of linear, linear-logarithmic, exponential regressions, and centered isotonic regression were used to determine the EC50 of Ropivacaine, and the residual standard errors were calculated for the comparison of "goodness of fit."
The concentration of Ropivacaine ranged from 0.1 to 0.35%. The EC50 (95% confidence interval) from 4 different statistical approaches (linear, linear-logarithmic, exponential regressions, and centered isotonic regression) were 0.222% (0.198%, 0.335%), 0.233% (0.215%, 0.453%), 0.223% (0.202%, 0.436%), and 0.232%, respectively. Among all the 4 models, the linear regression had the least residual standard error (0.1676).
The EC50 from the four statistical models for 10 ml Ropivacaine in ultrasound-guided ISBPB for postoperative analgesia was distributed in a narrow range of 0.222-0.233%.
www.chictr.org.cn/; registration number: ChiCTR2100047231.
肱骨近端骨折的神经支配复杂且尚不明确。肌间沟神经阻滞已被证明对患者术后镇痛有效,但最佳使用浓度尚不清楚。
本研究纳入30例ASA I或II级、计划行肱骨近端骨折手术的患者。采用序贯法确定肌间沟臂丛神经阻滞(ISBPB)时罗哌卡因的用量为10 ml。首例接受ISBPB患者的罗哌卡因初始浓度为0.3%。术后镇痛成功或失败后,下一位患者的局麻药浓度分别降低或升高0.05%。我们将术后镇痛成功定义为ISBPB后最初8小时内静息状态下视觉模拟量表(VAS)评分<4分。采用线性、线性对数、指数回归和中心等渗回归分析技术确定罗哌卡因的半数有效浓度(EC50),并计算残差标准误以比较“拟合优度”。
罗哌卡因浓度范围为0.1%至0.35%。4种不同统计方法(线性、线性对数、指数回归和中心等渗回归)得出的EC50(95%置信区间)分别为0.222%(0.198%,0.335%)、0.233%(0.215%,0.453%)、0.223%(0.202%,0.436%)和0.232%。在所有4种模型中,线性回归的残差标准误最小(0.1676)。
超声引导下ISBPB用于术后镇痛时,10 ml罗哌卡因的4种统计模型的EC50分布在0.222%至0.233%的狭窄范围内。